Nephros Inc. Files 8-K Report
Ticker: NEPH · Form: 8-K · Filed: Aug 26, 2024 · CIK: 1196298
| Field | Detail |
|---|---|
| Company | Nephros Inc (NEPH) |
| Form Type | 8-K |
| Filed Date | Aug 26, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, exhibits
TL;DR
NEPHROS files routine 8-K, mostly exhibits. No major news.
AI Summary
On August 26, 2024, Nephros Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update rather than a significant event. No specific financial figures or new business developments were detailed in the provided excerpt.
Why It Matters
This filing serves as a standard disclosure for Nephros Inc., providing updates on financial statements and exhibits to the SEC.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for financial statements and exhibits, indicating no immediate material changes or risks.
Key Players & Entities
- NEPHROS INC (company) — Registrant
- August 26, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-32288 (commission_file_number) — SEC File Number
- 13-3971809 (irs_number) — IRS Employer Identification No.
- 380 Lackawanna Place, South Orange, New Jersey 07079 (address) — Address of principal executive offices
- 201.343.5202 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Nephros Inc.?
The primary purpose of this 8-K filing is to report financial statements and exhibits, as indicated by the 'ITEM INFORMATION' section.
On what date was this 8-K report filed or effective?
The report was filed as of August 26, 2024, and the date of the earliest event reported is also August 26, 2024.
What is the state of incorporation for Nephros Inc.?
Nephros Inc. is incorporated in Delaware.
What is the SEC file number for Nephros Inc.?
The SEC file number for Nephros Inc. is 001-32288.
Where are the principal executive offices of Nephros Inc. located?
The principal executive offices of Nephros Inc. are located at 380 Lackawanna Place, South Orange, New Jersey 07079.
Filing Stats: 509 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-08-26 16:05:23
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value NEPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 22KB
- ex99-1_001.jpg (GRAPHIC) — 365KB
- ex99-1_002.jpg (GRAPHIC) — 572KB
- ex99-1_003.jpg (GRAPHIC) — 258KB
- ex99-1_004.jpg (GRAPHIC) — 311KB
- ex99-1_005.jpg (GRAPHIC) — 330KB
- ex99-1_006.jpg (GRAPHIC) — 352KB
- ex99-1_007.jpg (GRAPHIC) — 203KB
- ex99-1_008.jpg (GRAPHIC) — 234KB
- ex99-1_009.jpg (GRAPHIC) — 274KB
- ex99-1_010.jpg (GRAPHIC) — 221KB
- ex99-1_011.jpg (GRAPHIC) — 245KB
- ex99-1_012.jpg (GRAPHIC) — 224KB
- ex99-1_013.jpg (GRAPHIC) — 240KB
- ex99-1_014.jpg (GRAPHIC) — 187KB
- ex99-1_015.jpg (GRAPHIC) — 250KB
- ex99-1_016.jpg (GRAPHIC) — 204KB
- ex99-1_017.jpg (GRAPHIC) — 257KB
- ex99-1_018.jpg (GRAPHIC) — 329KB
- ex99-1_019.jpg (GRAPHIC) — 254KB
- ex99-1_020.jpg (GRAPHIC) — 223KB
- ex99-1_021.jpg (GRAPHIC) — 221KB
- ex99-1_022.jpg (GRAPHIC) — 172KB
- ex99-1_023.jpg (GRAPHIC) — 205KB
- ex99-1_024.jpg (GRAPHIC) — 216KB
- ex99-1_025.jpg (GRAPHIC) — 324KB
- ex99-1_026.jpg (GRAPHIC) — 269KB
- ex99-1_027.jpg (GRAPHIC) — 40KB
- ex99-1_028.jpg (GRAPHIC) — 330KB
- ex99-1_029.jpg (GRAPHIC) — 241KB
- ex99-1_030.jpg (GRAPHIC) — 310KB
- ex99-1_031.jpg (GRAPHIC) — 311KB
- ex99-1_032.jpg (GRAPHIC) — 221KB
- 0001493152-24-033872.txt ( ) — 11798KB
- neph-20240826.xsd (EX-101.SCH) — 3KB
- neph-20240826_lab.xml (EX-101.LAB) — 33KB
- neph-20240826_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Nephros, Inc. Dated: August 26, 2024 By: /s/ Judy Krandel Judy Krandel Chief Financial Officer